Neurocrine Biosciences, Inc.
NBIX US64125C1099
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-11% | 35% | 10% | 4% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Gorman Kevin Charles |
126.41 USD |
106,322 Sold |
13,440,281 USD |
07/08/2025 | 07/08/2025 |
Delaet Ingrid SR OFF |
135.00 USD |
457 Sold |
61,695 USD |
10/07/2025 | 10/07/2025 |
Onyia Jude CSO |
130.46 USD |
59,819 Sold |
7,803,688 USD |
09/07/2025 | 09/07/2025 |
Onyia Jude CSO |
130.13 USD |
20,362 Sold |
2,649,738 USD |
02/07/2025 | 02/07/2025 |
Onyia Jude CSO |
130.13 USD |
20,362 Sold |
2,649,738 USD |
02/07/2025 | 02/07/2025 |
Gorman Kevin Charles |
120.38 USD |
9,613 Sold |
1,157,211 USD |
27/05/2025 | 27/05/2025 |
Gorman Kevin Charles |
120.38 USD |
9,613 Sold |
1,157,211 USD |
27/05/2025 | 27/05/2025 |
Rastetter William H |
110.20 USD |
30,000 Sold |
3,305,952 USD |
05/05/2025 | 05/05/2025 |
Rastetter William H |
110.20 USD |
30,000 Sold |
3,305,952 USD |
05/05/2025 | 05/05/2025 |
Roberts Eiry CMO |
115.04 USD |
500 Sold |
57,521 USD |
12/02/2025 | 14/02/2025 |